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Abstract
Background:  Cough in the patients with cough variant asthma is triggered by
bronchoconstriction, which responds to bronchodilator therapy. Following airway narrowing
induced by inhaled methacholine, deep inspiration (DI) causes dilation of the airways in both
asthmatic and non-asthmatic subjects. The aim of the present study was to investigate the
relationship between bronchodilator effect of DI and bronchoconstriction-triggered cough.
Methods: We measured airway responsiveness to methacholine using partial and full flow-volume
curves in 28 healthy adults. The expiratory flow at 40% above residual volume from the full forced
vital capacity (MEF40) was obtained and the volume was used as the reference volume to determine
the isovolume flow from the partial curve (PEF40). Coughs were counted for 32 min during and
following the inhalation of methacholine at the provocative concentration which produced a 20%
fall or more in FEV1from the post-saline value (PC20-FEV1). The bronchodilator effect of DI on
bronchoconstriction induced by methacholine at the PC20-FEV1 concentration was expressed as
the ratio of (MEF40-PEF40)/PEF40 (DI index).
Results: The number of coughs for 32 min during and following the inhalation of PC20-FEV1
concentration of methacholine was 39.3 ± 29.7 (mean ± SD)/32 min. The number of coughs during
and following the inhalation was correlated with DI index (r = 0.57, p = 0.0015), but not with PC20-
FEV1 or change in FEV1 or PEF40 by inhalation of the PC20-FEV1 concentration of methacholine.
Conclusion: We found that methacholine-induced cough was associated with the bronchodilator
effect of DI on methacholine induced-bronchoconstriction in normal subjects.
Introduction
Cough is a common and distressing symptom. Eosi-
nophilic airway disorders such as bronchial asthma (BA),
cough variant asthma (CVA) [1], eosinophilic bronchitis
without asthma [2], and atopic cough (AC) [3] are impor-
tant causes of chronic non-productive cough. As the
mechanism of cough, at least the following two are con-
sidered: one is a cough caused by cough reflex hypersensi-
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tivity that is relevant to AC, gastroesophageal reflux
disease (GERD) [4] and angiotensin-converting enzyme
inhibitor-induced cough [5]. Another is a cough triggered
by bronchoconstriction in such as CVA and BA, which
responds to bronchodilator therapy [1,6].
Capsaicin has achieved widespread use for measurement
of cough reflex sensitivity [7]. Several studies suggest that
capsaicin-induced cough is mediated by the selective exci-
tation of C-fiber receptors, which have thin non-myeli-
nated vagal afferents, and by the subsequent release of
tachykinins. Recently, the C-fiber receptor for capsaicin
has been identified as transient receptor potential vanil-
loid 1 (TRPV1), which is expressed in guinea pigs. TRPV1
mediates cough induced by capsaicin [8]. An increased
expression of TRPV1 has also been reported in humans
with chronic cough [9]. On the other hand, the mecha-
nism of cough triggered by bronchoconstriction is not
clear yet. It has been reported that cough sensitivity to cap-
saicin or mannitol does not directly correlate to bronchoc-
onstriction in normal and asthmatic subjects [10-12].
Inhalation of methacholine produces bronchoconstric-
tion, and methacholine challenge test is usually done for
evaluating bronchial hyperresponsiveness (BHR) [13].
There are few reports concerning cough induced by meth-
acholine inhalation in human, because it is known that
methacholine is a bronchoconstrictor, but not an effica-
cious cough inducer [14].
It is well recognized that the response of the airways to
deep inspiration (DI) differs between asthmatic and non-
asthmatic subjects. Following airway narrowing induced
by inhaled methacholine, DI causes dilation of the air-
ways in both asthmatic and nonasthmatic subjects [15].
However, the magnitude of the bronchodilating effect is
usually less in asthmatic than in nonasthmatic subjects. It
has been suggested that the inability of DI to overcome
bronchoconstriction is a fundamental abnormality of
asthma, and could contribute to BHR [15].
The aim of the present study was to investigate the corre-
lation of cough triggered by methacholine-induced bron-
choconstriction to airway smooth muscle (ASM) tone and
bronchodilating effect of DI on methacholine-induced
bronchoconstriction in normal subjects.
Materials and methods
Subjects
Twenty-eight normal subjects [2 men and 26 women,
mean age 21.5 ± 1.3 (standard deviation, SD) years] were
selected from 30 randomly selected Japanese college stu-
dents who visited our pulmonary function laboratory for
actual training of pulmonary function testing including
methacholine challenge test using partial and full flow-
volume curves. Subjects with a history of wheezing were
excluded (Table 1). All subjects gave informed consent
before entering the study. The Ethics Committee of
Kanazawa University Hospital approved the present
study.
Study Design
We measured airway responsiveness to methacholine
using partial and full flow-volume curves in 28 normal
subjects. Study design is shown in Figure 1. Increasing
concentrations of methacholine were inhaled until a fall
of 20% or more in FEV1 (PC20-FEV1) from the post-saline
value occurred. After each concentration of methacholine
inhalation, partial and full flow-volume curves were
measured. Coughs were counted for 2 min during the
inhalation and for 30 min following the inhalation of
methacholine at PC20-FEV1. After cough count, the bron-
choconstriction was subsequently reversed with salbuta-
mol.
Methacholine inhalation challenge
Methacholine chloride was dissolved in physiologic
saline to make solutions of 0.04, 0.08, 0.16, 0.31, 0.63,
1.25, 2.5, 5, 10, 20, 40, 80, and 160 mg/ml. Physiologic
saline solution and methacholine were inhaled from a
nebulizer (DeVilbiss 646, DeVilbiss Health Care; Somer-
set, PA) operated by compressed air at 5 l/min. The neb-
ulizer output was 0.28 ml/2 min. Saline solution was
inhaled first for 2 min and partial and full flow volume
curves were measured using a computerized spirometer
Table 1: Characteristics of 28 non-asthmatic healthy young adults and values for FVC, FEV1, MEF40, PEF40 and (MEF40-PEF40)/PEF40 
ratio at baseline
Gender: 2 men and 26 women
Age: 21.5 ± 1.3 years old
Height: 159.9 ± 5.5 cm
Weight: 51.0 ± 5.6 kg
FVC: 3.46 ± 0.72 L (107.4 ± 13.4% of predicted value)
FEV1: 3.20 ± 0.62 L (97.7 ± 11.7% of predicted value)
FEV1/FVC ratio: 92.7 ± 4.2%
MEF40: 3.56 ± 0.72 L/s
PEF40: 3.41 ± 0.82 L/s
(MEF40-PEF40)/PEF40 ratio: 0.074 ± 0.22Cough 2009, 5:9 http://www.coughjournal.com/content/5/1/9
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Study design is shown with an example Figure 1
Study design is shown with an example. Increasing concentrations of methacholine (0.04, 0.08, 0.16, 0.31, 0.63, 1.25, 2.5, 
5, 10, 20, 40, 80, and 160 mg/ml) were inhaled until a fall of 20% or more in FEV1(PC20-FEV1) from the post-saline value 
occurred. After each concentration of methacholine inhalation, partial and full flow-volume curves were measured. Coughs 
were counted for 2 min during the inhalation and for 30 min following the inhalation of methacholine at PC20-FEV1. [(a) In this 
case].Cough 2009, 5:9 http://www.coughjournal.com/content/5/1/9
Page 4 of 8
(page number not for citation purposes)
(CHESTAC-9800; CHEST; Tokyo, Japan). After confirm-
ing that the change in FEV1 from the baseline value after
inhalation of saline solution was 10% or less, inhalation
of methacholine was started. Methacholine was inhaled
for 2 min by tidal mouth breathing wearing a nose clip,
and this was followed immediately by 3 measurements of
partial and full flow-volume curves at 1 min intervals and
the curve with the largest forced vital capacity (FVC) was
retained for analysis. Subjects avoided to deep inspiration
(DI) before the each measurements of partial and full
flow-volume curves. Increasing concentrations of metha-
choline were inhaled until PC20-FEV1.
Partial and full flow-volume curves
Partial and full flow-volume curves were measured by the
modified method of Fish and co-workers [15]. Flow-vol-
ume curve maneuvers were performed in the following
manner. After a period of normal tidal breathing subjects
momentarily held their breath at slightly above the end-
tidal inspiration (approx 60% of FVC) and then forcibly
expired to residual volume (RV) level. After reaching the
RV level, subjects inspired to total lung capacity (TLC)
level as rapidly as possible (this is deep inspiration.) and
then immediately performed forced expiration. The expir-
atory flow at 40% above RV level from the full forced vital
capacity (MEF40) was obtained and the volume level was
used as the reference volume level to determine the isovol-
ume flow from the partial curve (PEF40). The levels of end-
tidal inspirations were similarly adjusted in all partial
flow-volume curves. (Figure 1)
The bronchodilating effect of DI on methacholine
induced-bronchoconstriction was expressed as the ratio of
(MEF40-PEF40)/PEF40 [16] (Figure 2). Especially, the ratio
of (MEF40-PEF40)/PEF40 after the inhalation of PC20-FEV1
concentration of methacholine was defined as DI index.
DI index means bronchodilating effect of deep inspiration
following measurements of partial flow-volume curves on
PC20-FEV1concentration of methacholine-induced bron-
choconstoriction.
Data analysis
Values of PC20-FEV1, concentration of methacholine
which produced 35% or more fall in MEF40 (PC35-MEF40)
and PEF40(PC35-PEF40) were expressed as geometric
means with the geometric standard error of the mean
(GSEM) expressed as a factor. Values for FVC, FEV1,
MEF40, and PEF40 were reported as arithmetic means and
standard deviations of the mean (SD). Wilcoxon signed-
ranks test was applied to assess the change in the ratio of
(MEF40-PEF40)/PEF40. We constructed simple regression
models to evaluate the relationship between any pairs of
the number of coughs for 32 min during and following
the inhalation of PC20-FEV1  concentration of metha-
choline, DI index, concentration of inhaled methacholine
and changes in FEV1 and PEF40 by the methacholine inha-
Examples of partial and full expiratory flow-volume curves before (a) and after (b) inhalation of methacholine in a young woman Figure 2
Examples of partial and full expiratory flow-volume curves before (a) and after (b) inhalation of methacholine 
in a young woman. Partial curves were performed from end-tidal inspiration; upon reaching residual volume level, subjects 
inspired to total lung capacity level and performed the full curve. In this example MEF40 was greater than PEF40 before metha-
choline inhalation, and the difference became much more after inhalation of 0.5 mg/ml of methacholine, indicating stronger 
bronchodilator effect of deep inspiration (DI) on methacholine-induced bronchoconstriction.Cough 2009, 5:9 http://www.coughjournal.com/content/5/1/9
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lation. In all analyses, values of p < 0.05 were considered
statistically significant.
Results
The mean values for FVC, % predicted value of FVC, FEV1,
% predicted value of FEV1, FEV1/FVC ratio, MEF40, PEF40,
(MEF40-PEF40)/PEF40 are shown in Table 1. The geometric
mean values for PC20-FEV1, PC35-MEF40, and PC35-PEF40,
the mean value for percent change in FEV1, MEF40, and
PEF40 from the baseline value, DI index and the number
of coughs for 32 min during and following the inhalation
of PC20-FEV1 concentration of methacholine are shown in
Table 2. In 9 (32.1%) of 28 normal subjects, 20% or more
fall in FEV1 did not occur at the final concentration of
methacholine solution (160 mg/ml), and the PC20-FEV1
value for these subjects was assumed to be 320 mg/ml for
statistical analysis. 35% or more fall in MEF40 was not pro-
duced by the final concentration of methacholine in 4
(14.2%) of 28 subjects and the PC35-MEF40 value for these
subjects was assumed to be 320 mg/ml for statistical anal-
ysis. On the other hand, 35% or more fall in PEF40was
produced by 160 mg/ml or less of methacholine in all
subjects.
The mean value for the ratio of (MEF40-PEF40)/PEF40 fol-
lowing inhalation of methacholine at individual concen-
tration causing 20% or more fall in FEV1 (DI index) was
significantly increased from the baseline value. (0.41 ±
0.39 from 0.074 ± 0.22, p = 0.003) [Figure 3].
The number of coughs for 32 min during and following
the inhalation of PC20-FEV1  concentration of metha-
choline was 39.3 ± 29.7/32 min. As shown in Figure 4, the
number of coughs during and following the inhalation
was significantly correlated with DI index (r = 0.57, p =
0.0015), but not with PC20-FEV1 concentration of metha-
choline (r = 0.22, p = 0.26), or change in FEV1 (r = 0.30, p
= 0.12) or PEF40 (r = 0.31, p = 0.11) by inhalation of the
PC20-FEV1 concentration of methacholine.
Discussion
In this study, we measured airway responsiveness to
methacholine using partial and full flow-volume curves
and coughs caused by the inhalation of PC20-FEV1 concen-
tration of methacholine in 28 normal subjects. The bron-
chodilating effect of DI on methacholine induced-
bronchoconstriction was evaluated using the ratio of
(MEF40-PEF40)/PEF40. We found that methacholine-
induced cough was associated with the bronchodilating
effect of DI on methacholine induced-bronchoconstric-
tion, but not with PC20-FEV1 concentration of inhaled
methacholine or the provocation-induced decrease in
FEV1 in normal subjects. We, therefore, suggest that cough
triggered by bronchoconstriction is regulated by protec-
tive response against bronchoconstriction, but not by the
magnitude of bronchoconstriction. Canning et al. [17]
Table 2: Airway responsiveness to methacholine, DI index and number of coughs for 32 min during and following the inhalationof 
methacholine
Airway responsiveness
PC20-FEV1 71.6 (GSEM, 1.28) mg/ml
PC35-MEF40 21.1 (GSEM, 1.28) mg/ml
PC35-PEF40 6.22 (GSEM, 1.27) mg/ml
After inhalation of PC20-FEV1 concentration of methacholine
Percent decrease in FEV1 from the baseline value 22.0 ± 9.0%
Percent decrease in MEF40 from the baseline value 53.4 ± 20.8%
Percent decrease in PEF40 from the baseline value 63.0 ± 18.2%
(MEF40-PEF40)/PEF40 ratio (DI index) 0.41 ± 0.39
Number of coughs 39.3 ± 29.7/32 min
Deep inspiration (DI) effect on bronchomotor tone before  and after inhalation of methacholine at individual concentra- tion causing 20% or more fall in FEV1 Figure 3
Deep inspiration (DI) effect on bronchomotor tone 
before and after inhalation of methacholine at indi-
vidual concentration causing 20% or more fall in 
FEV1. (MEF40-PEF40)/PEF40 ratio was calculated as an index of 
DI effect on bronchomotor tone.Cough 2009, 5:9 http://www.coughjournal.com/content/5/1/9
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reported in anesthetized guinea pigs that the administra-
tion of methacholine via the pulmonary artery caused
bronchoconstriction and vigorously activated rapidly
adapting receptors.
DI can affect acute airway narrowing by following two
mechanisms: bronchoprotection and bronchodilation.
Scichilone and coworkers [18] studied on bronchoprotec-
tion and bronchodilation in normal subjects. Wan and
coworkers [19] studied on these mechanisms in an in vivo
preparation of guinea pig airway smooth muscle (ASM).
Bronchoprotection was defined in these studies as the
reduction in bronchoconstriction resulting from act of DI
before the ASM has been stimulated to constrict [19] and
bronchodilation as the reduction in bronchoconstriction
after ASM activation by spasmogen. Scichilone and cow-
orkers reported that the bronchoprotective effects of DI
were stronger than the bronchodilating effects and also
that bronchoprotection was absent in asthmatics [18,20].
The effect of stretch on ASM preparations was found to be
consistent with the change observed in in vivo studies [19],
which suggests that the effects of DI on airway narrowing
are indeed mediated by its action on ASM.
It has been shown that in asthmatics there is impaired dil-
atation of the airways in response to stretch [15,21]. This
is based on the differences in the response of asthmatic
subjects to DI compared with normal subjects. Fish and
associates [15] measured changes in airway conductance
and partial flow-volume curves in response to metha-
choline inhalation in asthmatics and patients with allergic
rhinitis before and after DI. Although asthmatics showed
greater airway narrowing as assessed by either measure-
ment, the difference between asthmatic and rhinitis
patients was much less prior to than after DI. They sug-
gested that failure of bronchodilating effect of DI was an
important cause of airway hyperresponsiveness in
asthma.
In this study, the number of coughs following metha-
choline inhalation was not correlated with concentration
of inhaled methacholine causing a 20% or more fall in
Correlation of number of methacholine-induced cough with deep inspiration (DI) effect on methacholine-induced bronchocon- striction (a), concentration of inhaled methacholine (b), intensity of methacholine-induced bronchoconstriction assessed by  FEV1 (c) and intensity of methacholine-induced bronchoconstriction assessed by PEF40 (d) Figure 4
Correlation of number of methacholine-induced cough with deep inspiration (DI) effect on methacholine-
induced bronchoconstriction (a), concentration of inhaled methacholine (b), intensity of methacholine-
induced bronchoconstriction assessed by FEV1 (c) and intensity of methacholine-induced bronchoconstriction 
assessed by PEF40 (d). Concentration of methacholine in this case means the concentration causing 20% or more fall in 
FEV1 in individual subjects.
 
A  B 
 
C 
D Cough 2009, 5:9 http://www.coughjournal.com/content/5/1/9
Page 7 of 8
(page number not for citation purposes)
FEV1, or the methacholine-induced change in FEV1 or
PEF40. Irwin and coworkers [22] studied to determine
whether any features of positive results of methacholine
inhalation challenge or the results of a one-week trial of
inhaled beta-agonist therapy were helpful in determining
whether the cough was due to asthma. They concluded
that the results of airway responsiveness to methacholine
could not predict the response of cough to asthma ther-
apy. These results suggest that severity of cough due to
bronchoconstriction does not necessarily consist with
BHR. It seems to be clinically important for the treatment
strategy of chronic cough [23] to distinguish between
cough caused by cough reflex hypersensitivity and cough
triggered by bronchoconstriction, because the former
doesn't react to the bronchodilator at all, and the latter
reacts to the bronchodilator. It is also possible that the
mechanism of cough is complex, with contributions from
airway inflammation, a heightened cough reflex, and
bronchoconstriction.
In conclusion, this is the report concerning cough trig-
gered by methacholine-induced bronchoconstriction in
humans. We found that bronchoconstriction-triggered
cough was associated with the bronchodilating effect of
DI on the induced-bronchoconstriction, but not with
PC20-FEV1  concentration of inhaled methacholine or
methacholine-induced decrease in FEV1 in normal sub-
jects. Further studies are needed to investigate the rela-
tionship among cough triggered by methacholine-
induced bronchoconstriction, ASM tone and bronchodi-
lating effect of DI on the methacholine-induced bron-
choconstriction in patients with CVA in comparison with
typical asthma, atopic cough and so on.
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